Page 301 - Read Online

Thirugnanam et al. Vessel Plus 2020;4:26 I http://dx.doi.org/10.20517/2574-1209.2020.18 Page 15 of 16

49. Du K, Herzig S, Kulkarni RN, Montminy M. TRB3: a tribbles homolog that inhibits Akt/PKB activation by insulin in liver. Science.
2003;300:1574-7.
50. Rotter V, Nagaev I, Smith U. Interleukin-6 (IL-6) induces insulin resistance in 3T3-L1 adipocytes and is, like IL-8 and tumor necrosis
factor-alpha, overexpressed in human fat cells from insulin-resistant subjects. J Biol Chem 2003;278:45777-84.
51. Skurk T, Alberti-Huber C, Herder C, Hauner H. Relationship between adipocyte size and adipokine expression and secretion. J Clin
Endocrinol Metab 2007;92:1023-33.
52. Bernstein RS, Grant N, Kipnis DM. Hyperinsulinemia and enlarged adipocytes in patients with endogenous hyperlipoproteinemia without
obesity or diabetes mellitus. Diabetes 1975;24:207-13.
53. Brook CG, Lloyd JK. Adipose cell size and glucose tolerance in obese children and effects of diet. Arch Dis Child 1973;48:301-4.
54. McLaughlin T, Sherman A, Tsao P, Gonzalez O, Yee G, et al. Enhanced proportion of small adipose cells in insulin-resistant vs insulin-
sensitive obese individuals implicates impaired adipogenesis. Diabetologia 2007;50:1707-15.
55. Weyer C, Foley JE, Bogardus C, Tataranni PA, Pratley RE. Enlarged subcutaneous abdominal adipocyte size, but not obesity itself,
predicts type II diabetes independent of insulin resistance. Diabetologia 2000 Dec;43:1498-506.
56. Laforest S, Labrecque J, Michaud A, Cianflone K, Tchernof A. Adipocyte size as a determinant of metabolic disease and adipose tissue
dysfunction. Crit Rev Clin Lab Sci 2015;52:301-13.
57. Ha EE, Bauer RC. Emerging roles for adipose tissue in cardiovascular disease. Arterioscler Thromb Vasc Biol 2018;38:e137-44.
58. Veilleux A, Houde VP, Bellmann K, Marette A. Chronic inhibition of the mTORC1/S6K1 pathway increases insulin-induced PI3K
activity but inhibits Akt2 and glucose transport stimulation in 3T3-L1 adipocytes. Mol Endocrinol 2010;24:766-78.
59. Suthahar N, Meijers WC, Silljé HHW, de Boer RA. From inflammation to fibrosis-molecular and cellular mechanisms of myocardial
tissue remodelling and perspectives on differential treatment opportunities. Curr Heart Fail Rep 2017;14:235-50.
60. Van Linthout S, Tschöpe C. Inflammation - cause or consequence of heart failure or both? Curr Heart Fail Rep 2017;14:251-65.
61. Khan T, Muise ES, Iyengar P, Wang ZV, Chandalia M, et al. Metabolic dysregulation and adipose tissue fibrosis: role of collagen VI. Mol
Cell Biol 2009;29:1575-91.
62. Ko HJ, Zhang Z, Jung DY, Jun JY, Ma Z, et al. Nutrient stress activates inflammation and reduces glucose metabolism by suppressing
AMP-activated protein kinase in the heart. Diabetes 2009;58:2536-46.
63. Tikellis C, Thomas MC, Harcourt BE, Coughlan MT, Pete J, et al. Cardiac inflammation associated with a Western diet is mediated via
activation of RAGE by AGEs. Am J Physiol Endocrinol Metab 2008;295:E323-30.
64. Song X, Kusakari Y, Xiao CY, Kinsella SD, Rosenberg MA, et al. mTOR attenuates the inflammatory response in cardiomyocytes and
prevents cardiac dysfunction in pathological hypertrophy. Am J Physiol Cell Physiol 2010;299:C1256-66.
65. Palomer X, Salvadó L, Barroso E, Vázquez-Carrera M. An overview of the crosstalk between inflammatory processes and metabolic
dysregulation during diabetic cardiomyopathy. Int J Cardiol 2013;168:3160-72.
66. Travers JG, Kamal FA, Robbins J, Yutzey KE, Blaxall BC. Cardiac fibrosis: the fibroblast awakens. Circ Res 2016;118:1021-40.
67. Blüher M. The distinction of metabolically ‘healthy’ from ‘unhealthy’ obese individuals. Curr Opin Lipidol 2010;21:38-43.
68. Wernstedt Asterholm I, Tao C, Morley TS, Wang QA, Delgado-Lopez F, et al. Adipocyte inflammation is essential for healthy adipose
tissue expansion and remodeling. Cell Metab 2014;20:103-18.
69. Berg AH, Scherer PE. Adipose tissue, inflammation, and cardiovascular disease. Circ Res 2005;96:939-49.
70. Carmeliet P, Ferreira V, Breier G, Pollefeyt S, Kieckens L, et al. Abnormal blood vessel development and lethality in embryos lacking a
single VEGF allele. Nature 1996;380:435-9.
71. Risau W, Flamme I. Vasculogenesis. Annu Rev Cell Dev Biol 1995;11:73-91.
72. Prabhudesai S, Koceja C, Dey A, Eisa-Beygi S, Leigh NR, et al. Cystathionine β-synthase is necessary for axis development in vivo.
Front Cell Dev Biol 2018;6:14.
73. Eisa-Beygi S, Benslimane FM, El-Rass S, Prabhudesai S, Abdelrasoul MKA, et al. Characterization of endothelial cilia distribution
during cerebral-vascular development in Zebrafish [ Danio rerio]. Arterioscler Thromb Vasc Biol 2018;38:2806-18.
74. Leigh NR, Schupp MO, Li K, Padmanabhan V, Gastonguay A, et al. Mmp17b is essential for proper neural crest cell migration in vivo.
PLoS One 2013;8:e76484.
75. Pardanaud L, Yassine F, Dieterlen-Lievre F. Relationship between vasculogenesis, angiogenesis and haemopoiesis during avian ontogeny.
Development 1989;105:473-85.
76. Chun CZ, Kaur S, Samant GV, Wang L, Pramanik K, et al. Snrk-1 is involved in multiple steps of angioblast development and acts via
notch signaling pathway in artery-vein specification in vertebrates. Blood 2009;113:1192-9.
77. Eriksson J, Löfberg J. Development of the hypochord and dorsal aorta in the zebrafish embryo [Danio rerio]. J Morphol 2000;244:167-76.
78. Fouquet B, Weinstein BM, Serluca FC, Fishman MC. Vessel patterning in the embryo of the zebrafish: guidance by notochord. Dev Biol
1997;183:37-48.
79. Sumanas S, Jorniak T, Lin S. Identification of novel vascular endothelial-specific genes by the microarray analysis of the zebrafish cloche
mutants. Blood 2005;106:534-41.
80. Eilken HM, Adams RH. Dynamics of endothelial cell behavior in sprouting angiogenesis. Curr Opin Cell Biol 2010;22:617-25.
81. Uemura A, Kusuhara S, Katsuta H, Nishikawa S. Angiogenesis in the mouse retina: a model system for experimental manipulation. Exp
Cell Res 2006;312:676-83.
82. Nessa A, Latif SA, Siddiqui NI, Hussain MA, Bhuiyan MR, et al. Angiogenesis-a novel therapeutic approach for ischemic heart disease.
Mymensingh Med J 2009;18:264-72.
83. Mori J, Zhang L, Oudit GY, Lopaschuk GD. Impact of the renin-angiotensin system on cardiac energy metabolism in heart failure. J Mol